Acute lymphoblastic leukemia, childhood
Active Research Protocols
- 08-C-0123 – A Phase 1, Multi-Center, Dose Escalation Study of CAT-8015 in Children, Adolescents, and Young Adults with Refractory CD22+ Acute Lymphoblastic Leukemia (ALL) or Non-HodgkinÕs Lymphoma (NHL)
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014